Abstract

Many computational methods have been developed to infer cell type proportions from bulk transcriptomics data. However, an evaluation of the impact of data transformation, pre-processing, marker selection, cell type composition and choice of methodology on the deconvolution results is still lacking. Using five single-cell RNA-sequencing (scRNA-seq) datasets, we generate pseudo-bulk mixtures to evaluate the combined impact of these factors. Both bulk deconvolution methodologies and those that use scRNA-seq data as reference perform best when applied to data in linear scale and the choice of normalization has a dramatic impact on some, but not all methods. Overall, methods that use scRNA-seq data have comparable performance to the best performing bulk methods whereas semi-supervised approaches show higher error values. Moreover, failure to include cell types in the reference that are present in a mixture leads to substantially worse results, regardless of the previous choices. Altogether, we evaluate the combined impact of factors affecting the deconvolution task across different datasets and propose general guidelines to maximize its performance.

Inferring cell type proportions from transcriptomics data is affected by data transformation, normalization, choice of method and the markers used. Here, the authors use single-cell RNAseq datasets to evaluate the impact of these factors and propose guidelines to maximise deconvolution performance.

Details

Title
Benchmarking of cell type deconvolution pipelines for transcriptomics data
Author
Avila Cobos Francisco 1   VIAFID ORCID Logo  ; Alquicira-Hernandez, José 2   VIAFID ORCID Logo  ; Powell, Joseph E 2   VIAFID ORCID Logo  ; Mestdagh Pieter 3   VIAFID ORCID Logo  ; De Preter Katleen 3   VIAFID ORCID Logo 

 Ghent University, Center for Medical Genetics Ghent, Department of Biomolecular Medicine, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Cancer Research Institute Ghent (CRIG), Ghent, Belgium (GRID:grid.5342.0); Garvan Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924) 
 Garvan Weizmann Centre for Cellular Genomics, Garvan Institute of Medical Research, Sydney, Australia (GRID:grid.415306.5) (ISNI:0000 0000 9983 6924); Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia (GRID:grid.1003.2) (ISNI:0000 0000 9320 7537) 
 Ghent University, Center for Medical Genetics Ghent, Department of Biomolecular Medicine, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798); Cancer Research Institute Ghent (CRIG), Ghent, Belgium (GRID:grid.5342.0) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471540699
Copyright
© The Author(s) 2020. corrected publication 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.